ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction Chemoimmunotherapy
Clinical trial NCT05822284 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05822284
- Sponsor
- Second Xiangya Hospital of Central South University
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-04-01
- Primary completion
- 2029-03-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.